Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen

Free Radical Biology and Medicine

Volumn 29, Issue 3-4, 2000, Pages 231-240

  Dinkova Kostova, Albena T ^a   Talalay, Paul ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant response element (ARE); Benzene toxicity; Chemoprotection; Free radicals; Hydroquinones; Redox cycling; Sulforaphane

Indexed keywords

1,4 BENZOQUINONE; DICOUMAROL; GLUTATHIONE; HYDROQUINONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; BLOOD TOXICITY; CARCINOGENICITY; CATALYSIS; CELL PROTECTION; CYTOTOXICITY; ENZYME ACTIVITY; GENE DELETION; HUMAN; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW;

ANIMALIA; MURINAE;

EID: 0033805326     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00300-2     Document Type: Article

References (101)

1. Ernster L., Navazio F. Soluble diaphorase in animal tissues. Acta Chem. Scand. 12:1958;595.
2. Ernster L. DT diaphorase a historical review . Chem. Scripta. 27A:1987;1-13.
3. Liao S., Williams-Ashman H.G. Enzymatic oxidation of some nonphosphorylated derivatives of dihydronicotinamide. Biochem. Biophys. Res. Commun. 4:1961;208-213.
4. Liao S., Williams-Ashman H.G. Inhibition of the enzymic oxidation of some dihydropyrydines by polycyclic aromatic hydrocarbons. Biochem. Pharm. 6:1961;53-54.
5. Liao S., Dulaney J.T., Williams-Ashman H.G. Purification and properties of a flavoprotein catalyzing the oxidation of reduced ribosylnicotinamide. J. Biol. Chem. 237:1962;2981-2987.
6. Zhao Q., Yang X.L., Holtzclaw W.D., Talalay P. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT diaphorase). Proc. Natl. Acad. Sci. USA. 94:1997;1669-1674.
7. Jaiswal A.K. Human NAD(P)H:quinone oxidoreductase 2. Gene structure, activity, and tissue-specific expression. J. Biol. Chem. 269:1994;14502-14508.
8. Jaiswal A.K., Burnett P., Adesnik M., McBride O.W. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6. Biochemistry. 29:1990;1899-1906.
9. Foster C.E., Bianchet M.A., Talalay P., Zhao Q., Amzel L.M. Crystal structure of human quinone reductase type 2, a metalloflavoprotein. Biochemistry. 38:1999;9881-9886.
10. Li R., Bianchet M.A., Talalay P., Amzel L.M. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy. Proc. Natl. Acad. Sci. USA. 92:1995;8846-8850.
11. Märki F., Martius C. Vitamin K-Reduktase Darstellung und Eigenschaften . Biochem. Z. 333:1960;111-135.
12. Lind C., Hochstein P., Ernster L. DT diaphorase properties, reaction mechanism, metabolic function. A progress report . King T.E., Mason H.S., Morrison M. Oxidases and related redox systems. 1982;321-347 Pergamon Press, Oxford.
13. Prochaska H.J., Talalay P. The role of NAD(P)H:quinone reductase in protection against the toxicity of quinones and related agents. Sies H. Oxidative stress oxidants and antioxidants . 1991;195-211 Academic Press, London.
14. Cadenas E. Antioxidant and pro-oxidant functions of DT diaphorase in quinone metabolism. Biochem. Pharmacol. 49:1995;127-140.
15. 3(+)-induced neurotoxicity of dopamine prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase . Chem. Biol. Interact. 72:1989;309-324.
16. Öllinger K., Buffinton G.D., Ernster L., Cadenas E. Effect of superoxide dismutase on the autoxidation of substituted hydro-and semi-naphthoquinones. Chem. Biol. Interact. 73:1990;53-76.
17. Lind C. Formation of benzo[a]pyrene-3,6-quinol mono- and diglucuronides in rat liver microsomes. Arch. Biochem. Biophys. 240:1985;226-235.
18. Begleiter A., Leith M.K., Curphey T.J., Doherty G.P. Induction of DT diaphorase in cancer chemoprevention and chemotherapy. Oncol. Res. 9:1997;371-382.
19. Williams-Ashman H.G., Huggins C. Oxidation of reduced pyridine nucleotides in mammary gland and adipose tissue following treatment with polynuclear hydrocarbons. Med. Exper. 4:1961;223-226.
20. Lind C., Vadi H., Ernster L. Metabolism of benzo(a)pyrene-3,6-quinone and 3-hydroxybenzo(a)pyrene in liver microsomes from 3-methylcholanthrene-treated rats. A possible role of DT diaphorase in the formation of glucuronyl conjugates. Arch. Biochem. Biophys. 190:1978;97-108.
21. Welsch C.W. Host factors affecting growth of carcinogen-induced rat mammary carcinomas a review and tribute to Charles Brenton Huggins . Cancer Res. 45:1985;3415-3443.
22. Huggins C. Experimental leukemia and mammary cancer induction, prevention, cure . 1979;The University of Chicago Press, Chicago.
23. Huggins C., Pataki J. Aromatic azo derivatives preventing mammary cancer and adrenal injury from 7,12-dimethylbenz[a]anthracene. Proc. Natl. Acad. Sci. USA. 53:1965;791-796.
24. Wattenberg L.W. Inhibitors of chemical carcinogenesis. Adv. Cancer Res. 26:1979;197-226.
25. Benson A.M., Batzinger R.P., Ou S.Y., Bueding E., Cha Y.N., Talalay P. Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res. 38:1978;4486-4495.
26. Benson A.M., Cha Y.N., Bueding E., Heine H.S., Talalay P. Elevation of extrahepatic glutathione S-transferase and epoxide hydratase activities by 2(3)-tert-butyl-4-hydroxyanisole. Cancer Res. 39:1979;2971-2977.
27. Talalay P., Fahey J.W., Holtzclaw W.D., Prestera T., Zhang Y. Chemoprotection against cancer by Phase 2 enzyme induction. Toxicol. Lett. 82/83:1995;173-179.
28. Kensler T.W. Chemoprevention by inducers of carcinogen detoxication enzymes. Environ. Health Perspect. 105:(Suppl. 4):1997;965-970.
29. Benson A., Hunkeler M.J., Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants possible role in protection against carcinogenicity and toxicity . Proc. Natl. Acad. Sci. USA. 77:1980;5216-5220.
30. Iyanagi T., Yamazaki I. One-electron-transfer reactions in biochemical systems. V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT diaphorase). Biochim. Biophys. Acta. 216:1970;288-294.
31. Iyanagi T. On the mechanism of one- and two-electron transfer by flavin enzymes. Chem. Scripta. 27A:1987;31-36.
32. Prochaska H.J. Purification and crystallization of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase by Cibacron Blue affinity chromatography identification of a new and potent inhibitor . Arch. Biochem. Biophys. 267:1988;529-538.
33. Prochaska H.J., Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 48:1988;4776-4782.
34. Radjendirane V., Jaiswal A.K. Antioxidant response element-mediated 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induction of human NAD(P)H:quinone oxidoreductase 1 gene expression. Biochem. Pharmacol. 58:1999;1649-1655.
35. Lind C., Hochstein P., Ernster L. DT diaphorase as a quinone reductase a cellular control device against semiquinone and superoxide radical formation . Arch. Biochem. Biophys. 216:1982;178-185.
36. Chesis P.L., Levin D.E., Smith M.T., Ernster L., Ames B.N. Mutagenicity of quinones pathways of metabolic activation and detoxification . Proc. Natl. Acad. Sci. USA. 81:1984;1696-1700.
37. Joseph P., Jaiswal A.K. NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc. Natl. Acad. Sci. USA. 91:1994;8413-8417.
38. Wefers H., Komai T., Talalay P., Sies H. Protection against active oxygen species by NAD(P)H:quinone reductase induced by the dietary antioxidant butylated hydroxyanisole (BHA). Decreased hepatic low-level chemiluminescence during quinone redox cycling. FEBS Lett. 169:1984;63-66.
39. Prochaska H.J., Talalay P., Sies H. Direct protective effect of NAD(P)H:quinone reductase against menadione-induced chemiluminescence of postmitochondrial fractions of mouse liver. J. Biol. Chem. 262:1987;1931-1934.
40. Smart R.C., Zannoni V.G. DT diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol. Pharmacol. 26:1984;105-111.
41. Roy D., Liehr J.G. Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters. Increased superoxide formation by redox cycling of estrogen. J. Biol. Chem. 263:1988;3646-3651.
42. Thor H., Smith M.T., Hartzell P., Bellomo G., Jewell S.A., Orrenius S. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. J. Biol. Chem. 257:1982;12419-12425.
43. Mirabelli F., Salis A., Marinoni V., Finardi G., Bellomo G., Thor H., Orrenius S. Menadione-induced bleb formation in hepatocytes is associated with the oxidation of thiol groups in actin. Arch. Biochem. Biophys. 264:1988;261-269.
44. Lee S.-M., Cho T.-S., Kim D.-J., Cha Y.-N. Protective effect of ethanol against acetaminophen-induced hepatotoxicity in mice. Role of NADH:quinone reductase. Biochem. Pharm. 58:1999;1547-1555.
45. Karczewski J.M., Peters J.G., Noordhoek J. Quinone toxicity in DT diaphorase-efficient and -deficient colon carcinoma cell lines. Biochem. Pharmacol. 57:1999;27-37.
46. Benatti U., Guida L., De Flora A., Hochstein P. The effect of encapsulated DT diaphorase on the sensitivity of human red blood cells to menadione. Chem. Scripta. 27A:1987;169-171.
47. Munday R., Smith B.L., Munday C.M. Effects of butylated hydroxyanisole and dicoumarol on the toxicity of menadione to rats. Chem. Biol. Interact. 108:1998;155-170.
48. Prochaska H.J., Talalay P. Purification and characterization of two isofunctional forms of NAD(P)H:quinone reductase from mouse liver. J. Biol. Chem. 261:1986;1372-1378.
49. Beyer R.E. The relative essentiality of the antioxidative function of coenzyme Q - the interactive role of DT diaphorase. Mol. Aspects Med. 15:1994;S117-S129.
50. Beyer R.E., Segura-Aguilar J., Di Bernardo S., Cavazzoni M., Fato R., Fiorentini D., Galli M.C., Setti M., Landi L., Lenaz G. The role of DT diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc. Natl. Acad. Sci. USA. 93:1996;2528-2532.
51. Siegel D., Bolton E.M., Burr J.A., Liebler D.C., Ross D. The reduction of α-tocopherolquinone by human NAD(P)H:quinone oxidoreductase the role of α-tocopherolhydroquinone as a cellular antioxidant . Mol. Pharmacol. 52:1997;300-305.
52. Murphy T.H., De Long M.J., Coyle J.T. Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress. J. Neurochem. 56:1991;990-995.
53. Spencer S.R., Wilczak C.A., Talalay P. Induction of glutathione transferases and NAD(P)H:quinone reductase by fumaric acid derivatives in rodent cells and tissues. Cancer Res. 50:1990;7871-7875.
54. Duffy S., So A., Murphy T.H. Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage. J. Neurochem. 71:1998;69-77.
55. Nelson K.C., Carlson J.L., Newman M.L., Sternberg P. Jr, Jones D.P., Kavanagh T.J., Diaz D., Cai J., Wu M. Effect of dietary inducer dimethylfumarate on glutathione in cultured human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 40:1999;1927-1935.
56. Moehlenkamp J.D., Johnson J.A. Activation of antioxidant/electrophile-responsive elements in IMR-32 human neuroblastoma cells. Arch. Biochem. Biophys. 363:1999;98-106.
57. Ahlgren-Beckendorf J.A., Reising A.M., Schander M.A., Herdler J.W., Johnson J.A. Coordinate regulation of NAD(P)H:quinone oxidoreductase and glutathione S-transferases in primary cultures of rat neurons and glia role of the antioxidant/electrophile-responsive element . Glia. 25:1999;131-142.
58. Prochaska H.J., Santamaria A.B. Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells a screening assay for anticarcinogenic enzyme inducers . Anal. Biochem. 169:1988;328-336.
59. Prochaska H.J., Santamaria A.B., Talalay P. Rapid detection of inducers of enzymes that protect against carcinogens. Proc. Natl. Acad. Sci. USA. 89:1992;2394-2398.
60. Talalay P., De Long M.J., Prochaska H.J. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. USA. 85:1988;8261-8265.
61. Talalay P. Mechanisms of induction of enzymes that protect against chemical carcinogenesis. Adv. Enzyme Regul. 28:1989;237-250.
62. Zhang Y., Talalay P., Cho C.G., Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli isolation and elucidation of structure . Proc. Natl. Acad. Sci. USA. 89:1992;2399-2403.
63. Fahey J.W., Zhang Y., Talalay P. Broccoli sprouts an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens . Proc. Natl. Acad. Sci. USA. 94:1997;10367-10372.
64. Zhang Y., Kensler T.W., Cho C.G., Posner G.H., Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. USA. 91:1994;3147-3150.
65. Prestera T., Zhang Y., Spencer S.R., Wilczak C.A., Talalay P. The electrophile counterattack response protection against neoplasia and toxicity . Adv. Enzyme Regul. 33:1993;281-296.
66. Khachik F., Bertram J.S., Huang M.-T., Fahey J.W., Talalay P. Dietary carotenoids and their metabolites as potentially useful chemoprotective agents against cancer. Packer L., Hiramatsu M., Yoshikawa T. Antioxidant food supplements in human health. 1999;203-229 Academic Press, San Diego.
67. Putzer R.R., Zhang Y., Prestera T., Holtzclaw W.D., Wade K.L., Talalay P. Mercurials and dimercaptans synergism in the induction of chemoprotective enzymes . Chem. Res. Toxicol. 8:1995;103-110.
68. Rushmore T.H., Morton M.R., Pickett C.B. The antioxidant-responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266:1991;11632-11639.
69. Hayes J.D., Ellis E.M., Neal G.E., Harrison D.J., Manson M.M. Cellular response to cancer chemopreventive agents contribution of the antioxidant-responsive element to the adaptive response to oxidative and chemical stress . Biochem. Soc. Symp. 64:1999;141-168.
70. Prestera T., Talalay P., Alam J., Ahn Y.I., Lee P.J., Choi A.M.K. Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants regulation by upstream antioxidant-responsive elements (ARE) . Mol. Med. 1:1995;827-837.
71. Mulcahy R.T., Wartman M.A., Bailey H.H., Gipp J.J. Constitutive and β-naphthoflavone-induced expression of the human γ-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J. Biol. Chem. 272:1997;7445-7454.
72. Moinova H.R., Mulcahy R.T. An electrophile-responsive element (EpRE) regulates β-naphthoflavone induction of the human γ-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site. J. Biol. Chem. 273:1998;14683-14689.
73. Dalton T., Palmiter R.D., Andrews G.K. Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements. Nucleic Acids Res. 22:1994;5016-5023.
74. Primiano T., Sutter T.R., Kensler T.W. Antioxidant-inducible genes. Adv. Pharmacol. 38:1997;293-328.
75. Friling R.S., Bergelson S., Daniel V. Two adjacent AP-1-like binding sites form the electrophile-responsive element of the murine glutathione S-transferase Ya subunit gene. Proc. Natl. Acad. Sci. USA. 89:1992;668-672.
76. Favreau L.V., Pickett C.B. Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Characterization of a DNA protein interaction at the antioxidant-responsive element and induction by 12-O-tetradecanoylphorbol 13-acetate. J. Biol. Chem. 268:1993;19875-19881.
77. Wasserman W.W., Fahl W.E. Comprehensive analysis of proteins which interact with the antioxidant-responsive element correlation of ARE-BP-1 with the chemoprotective induction response . Arch. Biochem. Biophys. 344:1997;387-396.
78. Venugopal R., Jaiswal A.K. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene. Proc. Natl. Acad. Sci. USA. 93:1996;14960-14965.
79. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/Small Maf heterodimer mediates the induction of Phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res Commun. 236:1997;313-322.
80. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap 1 represses nuclear activation of antioxidant-responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Devel. 13:1999;76-86.
81. Wild A.C., Moinova H.R., Mulcahy R.T. Regulation of γ-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J. Biol. Chem. 274:1999;33627-33636.
82. Moinova H.R., Mulcahy R.T. Upregulation of the human γ-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile-responsive element. Biochem. Biophys. Res. Commun. 261:1999;661-668.
83. Chan K., Kan Y.K. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl. Acad. Sci. USA. 96:1999;12731-12736.
84. Henderson C.J., Smith A.G., Ure J., Brown K., Bacon E.J., Wolf C.R. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc. Natl. Acad. Sci. USA. 95:1998;5275-5280.
85. Radjendirane V., Joseph P., Lee Y.H., Kimura S., Klein-Szanto A.J., Gonzalez F.J., Jaiswal A.K. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J. Biol. Chem. 273:1998;7382-7389.
86. Zhu H., Li Y., Trush M.A. Differences in xenobiotic detoxifying activities between bone marrow stromal cells from mice and rats implications for benzene-induced hematotoxicity . J. Toxicol. Environ. Health. 46:1995;183-201.
87. Trush M.A., Twerdok L.E., Rembish S.J., Zhu H., Li Y. Analysis of target cell susceptibility as a basis for the development of a chemoprotective strategy against benzene-induced hematotoxicities. Environ. Health Perspect. 104:1996;1227-1234.
88. Smith M.T. Benzene, NQO1, and genetic susceptibility to cancer. Commentary. Proc. Natl. Acad. Sci. USA. 96:1999;7624-7626.
89. 609C → T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 57:1997;2839-2842.
90. Moran J.L., Siegel D., Ross D. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc. Natl. Acad. Sci. USA. 96:1999;8150-8155.
91. Edwards Y.H., Potter J., Hopkinson D.A. Human FAD-dependent NAD(P)H diaphorase. Biochem. J. 187:1980;429-436.
92. 4) to chromosome 16. Ann. Hum. Genet. 43:1980;349-353.
93. Traver R.D., Horikoshi T., Danenberg T., Stadlbauer T.H., Danenberg P.V., Ross D., Gibson N.W. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells characterization of a mutation that modulates DT diaphorase activity and mitomycin sensitivity . Cancer Res. 52:1992;797-802.
94. Traver R.D., Siegel D., Beall H.D., Phillips R.M., Gibson N.W., Franklin W.A., Ross D. Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT diaphorase). Br. J. Cancer. 75:1997;69-75.
95. Eickelmann P., Ebert T., Warskulat U., Schulz W.A., Sies H. Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases α and π in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogenesis. 15:1994;219-225.
96. Wiencke J.K., Spitz M.R., McMillan A., Kelsey K.T. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H:quinone oxidoreductase polymorphism. Canc. Biomark. Epidemiol. Preven. 6:1997;87-92.
97. Rosvold E., McGlynn K.A., Lustbader E.D., Buetow K. Identification of NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics. 5:1995;199-206.
98. Schulz W.A., Krummeck A., Rösinger I., Eickelmann P., Neuhaus C., Ebert T., Schmitz-Dräger B.J., Sies H. Increased frequency of a null-allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics. 7:1997;235-239.
99. 609C → T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood. 94:1999;803-807.
100. Clairmont A., Sies H., Ramachandran S., Lear J.T., Smith A.G., Bowers B., Jones P.W., Fryer A.A., Strange R.C. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci . Carcinogenesis. 20:1999;1235-1240.
101. Wiemels J.L., Pagnamenta A., Taylor G.M., Eden O.B., Alexander F.E., Greaves M.F. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. Cancer Res. 59:1999;4095-4099.